Put Options

20 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $734,046 - $781,174
-13,700 Reduced 96.48%
500 $28,000
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $553,280 - $777,660
-13,000 Reduced 47.79%
14,200 $801,000
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $357,198 - $516,927
11,100 Added 68.94%
27,200 $1.22 Million
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $534,820 - $607,420
12,100 Added 302.5%
16,100 $733,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $124,254 - $262,314
3,900 Added 3900.0%
4,000 $173,000
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $163,584 - $267,336
-3,600 Reduced 97.3%
100 $6,000
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $153,143 - $299,700
3,700 New
3,700 $166,000
Q2 2022

Aug 08, 2022

SELL
$87.2 - $114.05 $156,960 - $205,290
-1,800 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $75,352 - $99,592
800 Added 80.0%
1,800 $200,000
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $47,828 - $55,628
400 Added 66.67%
1,000 $128,000
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $196,506 - $256,230
-1,800 Reduced 75.0%
600 $80,000
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $160,544 - $185,104
1,600 Added 200.0%
2,400 $259,000
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $121,812 - $150,324
-1,200 Reduced 60.0%
800 $84,000
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $77,292 - $94,824
900 Added 81.82%
2,000 $208,000
Q3 2020

Nov 16, 2020

SELL
$72.74 - $92.5 $196,398 - $249,750
-2,700 Reduced 71.05%
1,100 $94,000
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $230,496 - $379,392
-4,800 Reduced 55.81%
3,800 $279,000
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $317,770 - $541,370
8,600 New
8,600 $447,000
Q3 2019

Nov 14, 2019

SELL
$47.45 - $58.05 $754,455 - $922,995
-15,900 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $620,308 - $856,518
15,800 Added 15800.0%
15,900 $862,000
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $2,984 - $4,392
100 New
100 $4,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.